Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Medison Pharma Announces the Expansion of its Partnership with Albireo to a Multi-Regional Agreement to Commercialize Odevixibat in Canada and Israel
2022-08-16 19:30
Profitable growth continues: Exyte with remarkable 6M/2022 results and uplifted year-end outlook
2022-08-16 16:24
ExoCoBio's First Global Regenerative Aesthetic Exosome Summit
2022-08-16 15:00
Sirnaomics Develops Peptide Docking Vehicle (PDoV(TM)) Designed for an Enhanced GalNAc Delivery Platform for Novel siRNA Therapeutics
2022-08-16 14:48
J INTS BIO, Oral presentation of Preclinical results of its Novel Oral 4th Generation EGFR TKI 'JIN-A02' at the 2022 World Conference on Lung Cancer in Vienna, Austria (IASLC 2022 WCLC)
2022-08-16 13:35
Antengene Announces First Patient Dosed of Small Molecule ATR ATG-018 for the Treatment of Patients with Advanced Solid Tumors and Hematologic Malignancies in Australia
2022-08-16 08:30
Bridge Biotherapeutics Receives FDA Authorization to Proceed with Phase 2 Study of BBT-877
2022-08-16 08:17
Everest Medicines Enters into Agreement with Gilead Sciences for Trodelvy in Asia Territories
2022-08-16 07:15
ROKIT Healthcare to Enable Innovation in Treatment of Diabetes Foot and Osteoarthritis Combining AI and 3D Bioprinting on Google Cloud
2022-08-15 07:00
Novavax Nuvaxovid™ COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17
2022-08-12 21:39
JIN-A02, A Novel 4th Generation EGFR TKI selected for the European Thoracic Oncology Platform - A First for Korean Pharma.
2022-08-12 10:13
WuXi ATU Announces Licensing Agreement with Janssen for TESSA™ Technology
2022-08-12 09:09
Everest Medicines Announces Regulatory Update and Strategic Partnership for Xerava™ in Taiwan
2022-08-11 08:00
Panacell Biotech to conduct toxicity tests for NK cells, exosomes, and brown adipose-derived stem cells to treat patients with long COVID
2022-08-10 22:00
WeTrade Group Entered Into A Strategic Partnership With Jiqing, Acquiring Monkeypox Test Kits Exclusive Sales Channel
2022-08-10 20:36
Recbio announces Phase III Clinical Trial Progress Of Recombinant HPV 9-Valent Vaccine
2022-08-10 16:06
Starpharma signs new DEP® agreement with MSD
2022-08-10 15:29
Bridge Biotherapeutics Presents Promising Interim Clinical Study Results from Phase 1 Study of BBT-176 at WCLC 2022
2022-08-10 11:43
MedAlliance SELUTION SLR Receives Second FDA IDE Approval
2022-08-10 10:00
iNtRON developed New CRISPR/Cas technology specific for Bacteriophage as PHAGERUS® Platform
2022-08-10 09:00
1
118
119
120
121
122
412